Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

YOGESH S JETHAVA

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1841622701
CMS profile
529762
Location
PARK RIDGE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$209,527.94

149 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–149 of 149 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

YOGESH S JETHAVA

NPI 1841622701 · CMS profile ID 529762

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology

PARK RIDGE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–149 of 149 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1841622701?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
YOGESH S JETHAVA, NPI 1841622701, CMS profile ID 529762. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–149 of 149 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1841622701?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). YOGESH S JETHAVA, NPI 1841622701, CMS profile ID 529762. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–149 of 149 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1841622701?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
YOGESH S JETHAVA, NPI 1841622701, CMS profile ID 529762, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–149 of 149 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1841622701?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

149 matching records · $209,527.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 149 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–149 of 149.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ADC Therapeutics America, Inc. $5,840.0004/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064321 CMS
BeiGene USA, Inc. $108.8604/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794363 CMS
BeiGene USA, Inc. $3,900.0004/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794365 CMS
BeiGene USA, Inc. $19.0004/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794367 CMS
BeiGene USA, Inc. $56.8404/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794369 CMS
BeiGene USA, Inc. $19.0004/27/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794371 CMS
BeiGene USA, Inc. $5,200.0004/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794373 CMS
BeiGene USA, Inc. $93.9504/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794375 CMS
ADC Therapeutics America, Inc. $7,300.0004/26/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064313 CMS
ADC Therapeutics America, Inc. $1,111.5004/26/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064317 CMS
Janssen Biotech, Inc. $10.9804/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885895475 CMS
Novartis Pharmaceuticals Corporation $91.0704/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893789955 CMS
ADC Therapeutics America, Inc. $89.9204/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064319 CMS
GENZYME CORPORATION $2,289.0004/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939150221 CMS
GENZYME CORPORATION $4.5004/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939150223 CMS
Janssen Scientific Affairs, LLC $125.0004/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887212435 CMS
BeiGene USA, Inc. $8.1604/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794361 CMS
ADC Therapeutics America, Inc. $1,139.2804/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064311 CMS
ADC Therapeutics America, Inc. $5,840.0004/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064309 CMS
ADC Therapeutics America, Inc. $115.2004/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064307 CMS
ADC Therapeutics America, Inc. $2,190.0003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064305 CMS
E.R. Squibb & Sons, L.L.C. $3,665.0003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899379 CMS
E.R. Squibb & Sons, L.L.C. $2,750.0003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899387 CMS
E.R. Squibb & Sons, L.L.C. $64.7503/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899435 CMS
PFIZER INC. $3.9203/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949362069 CMS
ADC Therapeutics America, Inc. $347.2003/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064331 CMS
Celgene Corporation $21.9703/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899375 CMS
E.R. Squibb & Sons, L.L.C. $29.5003/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899381 CMS
E.R. Squibb & Sons, L.L.C. $582.1103/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899383 CMS
E.R. Squibb & Sons, L.L.C. $18.7503/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899385 CMS
Incyte Corporation $307.5003/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943053349 CMS
TG Therapeutics, Inc. $3,375.0003/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940839559 CMS
Karyopharm Therapeutics Inc. $5,425.0003/01/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946532247 CMS
Karyopharm Therapeutics Inc. $1,086.2803/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946532253 CMS
Karyopharm Therapeutics Inc. $115.0003/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946532261 CMS
TG Therapeutics, Inc. $110.3702/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940839555 CMS
ADC Therapeutics America, Inc. $730.0002/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 922064303 CMS
Celgene Corporation $15.0702/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899479 CMS
Janssen Biotech, Inc. $1,350.0002/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885895375 CMS
ABBVIE INC. $4,050.0002/17/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892939065 CMS
BeiGene USA, Inc. $73.0002/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794351 CMS
BeiGene USA, Inc. $103.7102/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794353 CMS
BeiGene USA, Inc. $3,900.0002/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794355 CMS
BeiGene USA, Inc. $8.1102/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794357 CMS
Incyte Corporation $18.7902/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943053305 CMS
Janssen Biotech, Inc. $1,350.0002/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885895369 CMS
BeiGene USA, Inc. $1,625.0002/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940794359 CMS
Celgene Corporation $17.3302/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932899359 CMS
Karyopharm Therapeutics Inc. $1,550.0001/27/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946532241 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,368.88 31
PY2020 $11,735.87 14
PY2021 $134,072.85 91
PY2022 $209,527.94 149
PY2023 $129,212.79 98
PY2024 $90.38 1
PY2025 $63,784.66 69

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $218,327.69 7
PY2023 Recipient $6,400.00 7
PY2023 Principal investigator $251,399.73 31
PY2022 Recipient $1,270.00 2
PY2022 Principal investigator $176,063.09 53
PY2021 Principal investigator $96,534.40 9
PY2020 Recipient $1,270.00 2
PY2020 Principal investigator $126,664.28 16
PY2019 Principal investigator $10,982.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $21,606.00 07/31/2024 Non-covered Recipient Entity
FRANCISCAN HEALTH INDIANA BLOOD AND MARROW TRANSPLANTATION
An open label, multi-center Phase IIIB study of Asciminib (ABL001) monotherapy in patients with chronic myelogenous leukemia on chronic phase (CML-CP) previously treated with at least 2 prior TKIs (tyrosine kinase inhibitors) No dispute reported 06/30/2026 1089693423
Principal investigator 1 Novartis Pharmaceuticals Corporation $6,050.00 06/07/2024 Non-covered Recipient Entity
FRANCISCAN HEALTH INDIANAPOLIS AND MOORESVILLE
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase No dispute reported 06/30/2026 1089695311
Principal investigator 1 PFIZER INC. $25,398.20 05/09/2024 Covered Recipient Teaching Hospital
UNIVERSITY OF IOWA HOSP & CLINICS
A PHASE I OPEN LABEL STUDY TO EVALUATE THE SAFETY PHARMACOKINETIC PHARMACODYNAMIC AND CLINICAL ACTIVITY OF PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY AS A SINGLE AGENT AND IN COMBINATION WITH IMMUNOMODULATORY AGENTS IN PATIENTS WITH RELAPSEDREFRACTORY ADVANCED MULTIPLE MYELOMA MM No dispute reported 06/30/2026 1130979142
Principal investigator 1 PFIZER INC. $29,323.50 04/04/2024 Covered Recipient Teaching Hospital
UNIVERSITY OF IOWA HOSP & CLINICS
A PHASE I OPEN LABEL STUDY TO EVALUATE THE SAFETY PHARMACOKINETIC PHARMACODYNAMIC AND CLINICAL ACTIVITY OF PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY AS A SINGLE AGENT AND IN COMBINATION WITH IMMUNOMODULATORY AGENTS IN PATIENTS WITH RELAPSEDREFRACTORY ADVANCED MULTIPLE MYELOMA MM No dispute reported 06/30/2026 1130979711
Principal investigator 1 PFIZER INC. $68.31 02/29/2024 Covered Recipient Teaching Hospital
Franciscan Health Indianapolis
ELRANATAMAB PF06863135 MONOTHERAPY EXPANDED ACCESS PROTOCOL FOR TREATMENT OF PATIENTS WITH RELAPSEDREFRACTORY MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR ONE IMMUNOMODULATORY DRUG AND ONE ANTICD38 ANTIBODY AND HAVE NO ACCESS TO OTHER COMPARABLEALTERNATIVE THERAPY No dispute reported 06/30/2026 1130979906
Principal investigator 1 PFIZER INC. $15,250.00 02/22/2024 Covered Recipient Teaching Hospital
UNIVERSITY OF IOWA HOSP & CLINICS
A PHASE I OPEN LABEL STUDY TO EVALUATE THE SAFETY PHARMACOKINETIC PHARMACODYNAMIC AND CLINICAL ACTIVITY OF PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY AS A SINGLE AGENT AND IN COMBINATION WITH IMMUNOMODULATORY AGENTS IN PATIENTS WITH RELAPSEDREFRACTORY ADVANCED MULTIPLE MYELOMA MM No dispute reported 06/30/2026 1130980476
Principal investigator 1 Novartis Pharmaceuticals Corporation $120,631.68 01/15/2024 Non-covered Recipient Entity
FRANCISCAN HEALTH INDIANA BLOOD AND MARROW TRANSPLANTATION
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase No dispute reported 06/30/2026 1089693427